ZA938014B - Bradykinin antagonists. - Google Patents

Bradykinin antagonists.

Info

Publication number
ZA938014B
ZA938014B ZA938014A ZA938014A ZA938014B ZA 938014 B ZA938014 B ZA 938014B ZA 938014 A ZA938014 A ZA 938014A ZA 938014 A ZA938014 A ZA 938014A ZA 938014 B ZA938014 B ZA 938014B
Authority
ZA
South Africa
Prior art keywords
bradykinin antagonists
bradykinin
antagonists
Prior art date
Application number
ZA938014A
Other languages
English (en)
Inventor
John C Cheronis
Val Smith Goodfellow
Lyle W Spruce
James K Blodgett
Manoj V Marathe
Eric T Whalley
Original Assignee
Cortech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortech Inc filed Critical Cortech Inc
Publication of ZA938014B publication Critical patent/ZA938014B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA938014A 1992-11-10 1993-10-27 Bradykinin antagonists. ZA938014B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97400092A 1992-11-10 1992-11-10

Publications (1)

Publication Number Publication Date
ZA938014B true ZA938014B (en) 1994-07-11

Family

ID=25521455

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938014A ZA938014B (en) 1992-11-10 1993-10-27 Bradykinin antagonists.

Country Status (11)

Country Link
EP (1) EP0671941A4 (es)
JP (1) JPH08503460A (es)
CN (1) CN1094058A (es)
AU (1) AU5410994A (es)
CA (1) CA2147869A1 (es)
IL (1) IL107400A0 (es)
MX (1) MX9306988A (es)
NZ (1) NZ257477A (es)
PL (1) PL304654A1 (es)
WO (1) WO1994011021A1 (es)
ZA (1) ZA938014B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003308A1 (en) * 1993-07-23 1995-02-02 Toray Industries, Inc. Morphinan derivative and medicinal use
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
DE69627191T2 (de) * 1995-06-09 2004-01-08 The Regents Of The University Of Michigan, Ann Arbor Bradikininanaloge als selektive thrombininhibitoren
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6359111B1 (en) * 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
WO2003020200A2 (en) 2000-11-16 2003-03-13 New River Pharmaceuticals Inc. A novel pharmaceutical compound and methods of making and using same
EP1357928B1 (en) * 2000-11-16 2011-11-16 Shire LLC A novel pharmaceutical compound and methods of making and using same
AU2001297565B2 (en) * 2000-11-16 2008-06-05 Takeda Pharmaceutical Company Limited A novel pharmaceutical compound and methods of making and using same
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7375082B2 (en) 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US7338939B2 (en) 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
WO2003072046A2 (en) 2002-02-22 2003-09-04 New River Pharmaceuticals Inc. Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
AR040956A1 (es) 2002-07-31 2005-04-27 Schering Ag Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
JP2006505627A (ja) * 2002-07-31 2006-02-16 シエーリング アクチエンゲゼルシャフト 新規エフェクター接合体、それらの生成方法及びそれらの医薬使用
EA008864B1 (ru) 2003-09-30 2007-08-31 Нью Ривер Фармасьютикалз Инк. Фармацевтические композиции для предотвращения передозировки или неправильного употребления лекарственных средств
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
CZ203693A3 (en) * 1991-04-01 1994-07-13 Cortech Bradykinin antagonists
SE9101472D0 (sv) * 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist

Also Published As

Publication number Publication date
PL304654A1 (en) 1995-01-09
EP0671941A4 (en) 1996-05-29
CN1094058A (zh) 1994-10-26
MX9306988A (es) 1995-01-31
JPH08503460A (ja) 1996-04-16
CA2147869A1 (en) 1994-05-26
NZ257477A (en) 1996-07-26
IL107400A0 (en) 1994-01-25
EP0671941A1 (en) 1995-09-20
WO1994011021A1 (en) 1994-05-26
AU5410994A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (en) Auto-reclosers.
ZA938014B (en) Bradykinin antagonists.
EP0586613A4 (en) Bradykinin antagonists
IL105877A0 (en) Angiotensin ii antagonists
ZA916711B (en) Bradykinin antagonists
EP0602449A3 (de) IC-Karte.
EP0633771A4 (en) Compounds.
EP0663839A4 (en) COMBINATIONS OF IBUPROFEN WITH A H2 ANTAGONIST.
EP0572808A3 (de) Antiblockierregelsystem.
SG50426A1 (en) Lhrh antagonists
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
ZA937127B (en) Catch.
EP0599191A3 (en) Engine speed control circuit.
HUT68862A (en) Endothelin antagonists ii.
ZA931481B (en) Implants.
EP0653246A3 (en) Atomizer.
EP0592354A3 (de) Vakuum-Zentrifuge.
EP0586848A3 (de) Implantat.
EP0663819A4 (en) IBUPROFEN-COFFEINE COMBINATIONS.
EP0624089A4 (en) Methods.
ZA935828B (en) New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
ZA931403B (en) Sulphonamidocarboxamides.
ZA939705B (en) Inhalter devices.
ZA931630B (en) Securing means.